BODYCAP

Their core work

BODYCAP is a French MedTech SME that develops thermal imaging technology and software systems for clinical medical applications. Their work combines thermal cameras, smartphone platforms, and image processing algorithms to create diagnostic tools for chronic disease management — most notably diabetic foot ulcer detection and prevention. They also have experience in the micro-fabrication of medical devices, having participated in an ECSEL pilot line program for advanced medical hardware manufacturing. As an industry partner in research consortia, they translate laboratory-stage technology into practical clinical products.

What they specialise in

How they've shifted over time

BODYCAP's early H2020 work (2015–2018) was anchored in medical device manufacturing infrastructure — InForMed involved building an integrated pilot line for micro-fabricated devices, with no recorded application-specific keywords, suggesting a hardware and fabrication focus. Their later project STANDUP (2018–2023) marks a decisive shift toward a specific clinical application: smartphone-delivered thermal diagnostics for diabetes complications, with a dense cluster of application-domain keywords including thermography, image processing, insoles, and clinical trials. The trajectory is clear: from manufacturing capability toward full-stack digital health product development with a defined therapeutic target.

BODYCAP is moving from broad medical hardware manufacturing toward a focused digital health product for diabetes management, a commercially growing area driven by Europe's chronic disease burden.

How they like to work

BODYCAP has participated in both projects purely as a consortium partner, never coordinating — which indicates they contribute defined technical expertise rather than driving research strategy. Despite only two projects, they have engaged with 46 unique partners across 13 countries, meaning both consortia (ECSEL-IA and MSCA-RISE) were large, multi-national programs where BODYCAP played a specialist industry role. This profile fits a company that joins well-structured consortia to deploy and validate its core technology within a broader research effort.

With 46 consortium partners across 13 countries from just 2 projects, BODYCAP's network is disproportionately broad for its project count — a direct result of participating in large ECSEL and MSCA schemes that routinely include 15–30 partners each. Their network spans multiple EU member states, reflecting genuine European integration.

What sets them apart

BODYCAP sits at an unusual intersection: thermal imaging hardware, smartphone software, and clinical diabetes care — a combination very few SMEs can credibly claim. Their dual track across micro-fabrication (InForMed) and clinical application development (STANDUP) means they can speak both the manufacturing and the clinical validation language in a consortium. For partners building digital health consortia targeting chronic disease, BODYCAP offers an industry partner with hands-on product experience rather than purely academic knowledge.

Highlights from their portfolio

• STANDUP
  Combines smartphone platforms, thermal cameras, clinical trials, and insole sensors into a single coherent product for diabetic foot ulcer prevention — a commercially concrete and medically urgent application rarely seen in MSCA projects.
• InForMed
  An ECSEL Innovation Action — one of the most competitive and industry-focused EU funding instruments — placing BODYCAP inside a high-value micro-fabricated medical device manufacturing consortium.